Cerity Partners’s Mersana Therapeutics MRSN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$95K Buy
12,832
+3,063
+31% +$22.7K ﹤0.01% 2486
2025
Q1
$84.1K Buy
+9,769
New +$84.1K ﹤0.01% 2336